Salivary testosterone in female-to-male transgender adolescents during treatment with intra-muscular injectable testosterone esters. 2013

Hong N Bui, and Sebastian E E Schagen, and Daniel T Klink, and Henriette A Delemarre-van de Waal, and Marinus A Blankenstein, and Annemieke C Heijboer
Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands.

BACKGROUND In our hospital, female-to-male (FtM) transgender adolescents from the age of 16 are treated with two- or four-weekly intra-muscular injections of testosterone-esters. Some patients treated with four-weekly injections have complaints of fatigue and experience mood swings towards the end of the inter-injection period, which calls for an evaluation of the time-course of testosterone levels between injections. Evaluation of salivary testosterone is a practical approach for sequential measurements. Since only ∼2% of total serum testosterone is present in saliva, a sensitive assay is necessary. The objective was to develop an isotope dilution-liquid chromatography-tandem mass spectrometry method (ID-LC-MS/MS) for salivary testosterone measurements and to evaluate the testosterone profiles after testosterone-ester mixture injections in FtM-adolescents. METHODS FtM treated with 125 mg/2 weeks or with 250 mg/4 weeks depots of testosterone-ester mixture collected saliva at different time intervals. Salivary testosterone was measured by a thoroughly validated ID-LC-MS/MS assay. RESULTS An ID-LC-MS/MS method for measuring salivary testosterone was developed with adequate accuracy and specificity. The reference range was established at 135-400 pmol/L. Testosterone levels peaked supra-physiologically immediately post-injection, and decreased to levels within the male reference range after nine days in all patients. 250 mg/4 weeks depots resulted in values below the reference range at the end of the 4 weeks. CONCLUSIONS The development of an adequate ID-LC-MS/MS method for measuring salivary testosterone allowed us to investigate the testosterone profile in FtM-adolescents after testosterone-esters mixture injections. These injections lead to extreme concentrations which may affect the wellbeing of the patients.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D008297 Male Males
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000728 Androgens Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. Androgen,Androgen Receptor Agonist,Androgen Effect,Androgen Effects,Androgen Receptor Agonists,Androgenic Agents,Androgenic Compounds,Agents, Androgenic,Agonist, Androgen Receptor,Agonists, Androgen Receptor,Compounds, Androgenic,Effect, Androgen,Effects, Androgen,Receptor Agonist, Androgen,Receptor Agonists, Androgen
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

Hong N Bui, and Sebastian E E Schagen, and Daniel T Klink, and Henriette A Delemarre-van de Waal, and Marinus A Blankenstein, and Annemieke C Heijboer
October 2011, Child and adolescent psychiatric clinics of North America,
Hong N Bui, and Sebastian E E Schagen, and Daniel T Klink, and Henriette A Delemarre-van de Waal, and Marinus A Blankenstein, and Annemieke C Heijboer
February 2024, Revista de neurologia,
Hong N Bui, and Sebastian E E Schagen, and Daniel T Klink, and Henriette A Delemarre-van de Waal, and Marinus A Blankenstein, and Annemieke C Heijboer
January 2018, Brain structure & function,
Hong N Bui, and Sebastian E E Schagen, and Daniel T Klink, and Henriette A Delemarre-van de Waal, and Marinus A Blankenstein, and Annemieke C Heijboer
September 2007, The journal of sexual medicine,
Hong N Bui, and Sebastian E E Schagen, and Daniel T Klink, and Henriette A Delemarre-van de Waal, and Marinus A Blankenstein, and Annemieke C Heijboer
March 1996, Pediatrics,
Hong N Bui, and Sebastian E E Schagen, and Daniel T Klink, and Henriette A Delemarre-van de Waal, and Marinus A Blankenstein, and Annemieke C Heijboer
January 2023, Ophthalmic plastic and reconstructive surgery,
Hong N Bui, and Sebastian E E Schagen, and Daniel T Klink, and Henriette A Delemarre-van de Waal, and Marinus A Blankenstein, and Annemieke C Heijboer
April 2021, BMC endocrine disorders,
Hong N Bui, and Sebastian E E Schagen, and Daniel T Klink, and Henriette A Delemarre-van de Waal, and Marinus A Blankenstein, and Annemieke C Heijboer
August 2023, Seminars in ophthalmology,
Hong N Bui, and Sebastian E E Schagen, and Daniel T Klink, and Henriette A Delemarre-van de Waal, and Marinus A Blankenstein, and Annemieke C Heijboer
August 2011, Psychoneuroendocrinology,
Hong N Bui, and Sebastian E E Schagen, and Daniel T Klink, and Henriette A Delemarre-van de Waal, and Marinus A Blankenstein, and Annemieke C Heijboer
August 2020, Journal of the neurological sciences,
Copied contents to your clipboard!